Scientific prize

Arnaud Lombard, winner of the ICAB 2022 prize


imgActu

Arnaud Lombard, F.R.S.-FNRS researcher in the GIGA neurosciences (Faculty of Medicine) is the winner of the first ICAB (Arsène Burny Cancer Institute) prize. This prize is awarded for his research on brain tumours and more particularly on glioblastoma.

A

rnaud Lombard graduated in medicine (2013) and neurosurgery in (2019) and defended his thesis in biomedical sciences in February 2019. He is currently a FNRS post-doctoral researcher in the laboratory of Prof. Bernard Rogister at GIGA-Neuroscience and Chief of Clinic in Neurosurgery at the University Hospital of Liège. His research focuses on establishing new targets and new therapies to fight glioblastoma, a malignant but very common primary brain tumour with a very poor prognosis (average survival of 18 months).

“My research project consists of carrying out mass spectrometry in the laboratory on tumour cells from patients, in order to identify new membrane markers specific to these cells. Once identified, these new membrane markers can be targeted through the production of tiny specific antibodies or "nanobodies". Finally, these nanobodies can be coupled to an oncolytic virus or a radioisotope, for example, in such a way as to specifically induce the death of cells that express the marker. »

Arnaud Lombard receives the first prize of the ICAB (Institut de Cancérologie Arsène Burny) created by the Fondation Léon Fréderic in collaboration with the ICAB of the CHU of Liege. This prize will enable him to finance part of his laboratory project on brain tumours and a training stay at the Pitié-Salpêtrière Hospital in Paris, also in the field of brain tumours.

About the ICAB Prize

The ICAB prize is a prize of the Fondation Léon Fréderic in collaboration with the Institut de Cancérologie Arsène Burny of the CHU of Liège. Awarded for the first time in 2022 on the occasion of the inauguration of the institute, the ICAB prize is intended to support a clinical, translational or fundamental research project in the field of cancer. The prize is worth 10,000 euros and is awarded annually. Half of the prize is intended for the winner and the other half is intended to support the operating costs of the project.

Contact 

Arnaud Lombard

Share this news